Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
Clinical trial NCT00563108 · UNKNOWN
Trial details
- NCT number
- NCT00563108
- Sponsor
- Hospital Authority, Hong Kong
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.